welcomes you to the new, improved website!Neil Moat, one of the busiest British surgeons involved directly and consistently in TAVR, discusses PARTNER 2 and SURTAVI, paying particular attention to the health economics of low-risk TAVR and the implication of reduced profile devices.
You are here:
Will TAVR Become the Predominant Method for Treating Severe Aortic Stenosis?
Submitted by: Aristotle Protopapas
Source: New England Journal of Medicine
Keywords:
Author(s): Moat NE
